NIH scientists defend industry ties while officials vow conflicts review; three investigations planned.
Also Senate approves spending bill.
FASEB urges 10 percent increase for NIH in FY 2005.
Oncologists lose money administering drugs to Medicare patients, survey finds.
ASCO to form commission to study tobacco problem.
Lymphoma Research Foundation names William Hawley president.
Funding Opportunities: NIH seeks “visionary thinkers” for awards of $2.5 million over five years. NCI RFA available.
Trending Stories
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - Blood Cancer United: A new name at the right moment
- With five-year cancer survival at an all-time high, does this mean people are living longer?
- An oncologist navigates terminal sarcoma, insurmountable debt, and “a legacy of grief”
How colleagues and Fargo, ND, neighbors came together to help the Erickson-Abou Zahrs - In The Headlines: Is early detection always good? Inside NCI’s MCD feasibility trial.
- Premarin’s 84-year hold on the market ends as FDA approves a generic version
Trade secret protections helped the hormone drug resist generic entry and outlast safety controversies—including link to cancer
